Patients on artificial pancreas show better glucose control

12/26/2013 | Family Practice News

A study presented at the World Diabetes Congress revealed adolescent type 1 diabetes patients who used a closed-loop continuous glucose monitoring system attained lower mean glucose levels and fewer nocturnal hypoglycemia incidents compared with those who used sensor-augmented pump therapy. Patients who used the artificial pancreas also had more time in blood glucose targets than the sensor-augmented pump arm, researchers noted.

View Full Article in:

Family Practice News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA